Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
McKesson
Dow
Accenture
Citi
Teva
Mallinckrodt
Cipla

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Otamixaban

« Back to Dashboard

US Patents for Otamixaban

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Otamixaban ➤ Sign Up Crystalline forms of a factor Xa inhibitor Aventis Pharmaceuticals Inc. (Bridgewater, NJ) ➤ Sign Up
Otamixaban ➤ Sign Up Inhibitors of bruton's tyrosine kinase Pharmacyclics, Inc. (Sunnyvale, CA) ➤ Sign Up
Otamixaban ➤ Sign Up Inhibitors of tyrosine kinases and uses thereof Pharmacyclics, Inc. (Sunnyvale, CA) ➤ Sign Up
Otamixaban ➤ Sign Up Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase Pharmacyclics, Inc. (Sunnyvale, CA) ➤ Sign Up
Otamixaban ➤ Sign Up Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase Pharmacyclics, Inc. (Sunnyvale, CA) ➤ Sign Up
Otamixaban ➤ Sign Up Inhibitors of bruton's tyrosine kinase Pharmacyclics, Inc. (Sunnyvale, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Otamixaban

Drugname Country Document Number Estimated Expiration Related US Patent
Otamixaban Austria 396177 2020-10-05 ➤ Sign Up
Otamixaban Australia 1142502 2020-10-05 ➤ Sign Up
Otamixaban Australia 2002211425 2020-10-05 ➤ Sign Up
Otamixaban Canada 2424565 2020-10-05 ➤ Sign Up
Otamixaban Cyprus 1108224 2020-10-05 ➤ Sign Up
Otamixaban Germany 60134162 2020-10-05 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Merck
Farmers Insurance
Chubb
US Department of Justice
Accenture
Queensland Health
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.